Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 570

    1.

    Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.

    Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, Bastard JP, Laville M, Vidal H.

    Diabetes. 2004 Sep;53(9):2232-41.PMID: 15331532 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.

    Ducluzeau PH, Perretti N, Laville M, Andreelli F, Vega N, Riou JP, Vidal H.

    Diabetes. 2001 May;50(5):1134-42.PMID: 11334418 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Expression and regulation by insulin of low-density lipoprotein receptor-related protein mRNA in human skeletal muscle.

    Boucher P, Ducluzeau PH, Davelu P, Andreelli F, Vallier P, Riou JP, Laville M, Vidal H.

    Biochim Biophys Acta. 2002 Dec 12;1588(3):226-31.PMID: 12393177 [PubMed - indexed for MEDLINE]Related articles

    4.

    Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans.

    Binnert C, Koistinen HA, Martin G, Andreelli F, Ebeling P, Koivisto VA, Laville M, Auwerx J, Vidal H.

    Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1072-9.PMID: 11052962 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects.

    Reyna SM, Ghosh S, Tantiwong P, Meka CS, Eagan P, Jenkinson CP, Cersosimo E, Defronzo RA, Coletta DK, Sriwijitkamol A, Musi N.

    Diabetes. 2008 Oct;57(10):2595-602. Epub 2008 Jul 15.PMID: 18633101 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.

    Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR.

    Diabetes. 1997 Jul;46(7):1230-4.PMID: 9200661 [PubMed - indexed for MEDLINE]Related articles

    7.

    Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.

    Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, Manco M, Calvani M, Castagneto M, Palacín M, Mingrone G, Zierath JR, Vidal H, Zorzano A.

    Diabetes. 2005 Sep;54(9):2685-93.PMID: 16123358 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin resistance-inducing cytokines differentially regulate SOCS mRNA expression via growth factor- and Jak/Stat-signaling pathways in 3T3-L1 adipocytes.

    Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R.

    J Endocrinol. 2004 Apr;181(1):129-38.PMID: 15072573 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus.

    Carper MJ, Cade WT, Cam M, Zhang S, Shalev A, Yarasheski KE, Ramanadham S.

    Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E558-67. Epub 2008 Jan 2.PMID: 18171911 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.

    Santangelo C, Scipioni A, Marselli L, Marchetti P, Dotta F.

    Eur J Endocrinol. 2005 Mar;152(3):485-9.PMID: 15757867 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice.

    Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, Hotamisligil GS, Van Obberghen E.

    J Biol Chem. 2001 Dec 21;276(51):47944-9. Epub 2001 Oct 16.PMID: 11604392 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.

    Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F.

    Diabetologia. 1997 Apr;40(4):421-9.PMID: 9112019 [PubMed - indexed for MEDLINE]Related articles

    14.

    Regulation of SOCS-3 expression by leptin and its co-localization with insulin receptor in rat skeletal muscle cells.

    Eguchi M, Gillis LC, Liu Y, Lyakhovsky N, Du M, McDermott JC, Sweeney G.

    Mol Cell Endocrinol. 2007 Mar 15;267(1-2):38-45. Epub 2007 Jan 16.PMID: 17223256 [PubMed - indexed for MEDLINE]Related articles

    15.

    Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

    Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA.

    J Biol Chem. 2003 Apr 18;278(16):13740-6. Epub 2003 Jan 30.PMID: 12560330 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.

    Koistinen HA, Bastard JP, Dusserre E, Ebeling P, Zegari N, Andreelli F, Jardel C, Donner M, Meyer L, Moulin P, Hainque B, Riou JP, Laville M, Koivisto VA, Vidal H.

    Eur J Clin Invest. 2000 Apr;30(4):302-10.PMID: 10759878 [PubMed - indexed for MEDLINE]Related articles

    17.

    Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

    Sreekumar R, Halvatsiotis P, Schimke JC, Nair KS.

    Diabetes. 2002 Jun;51(6):1913-20.PMID: 12031981 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients.

    Andreelli F, Laville M, Ducluzeau PH, Vega N, Vallier P, Khalfallah Y, Riou JP, Vidal H.

    Diabetologia. 1999 Mar;42(3):358-64.PMID: 10096790 [PubMed - indexed for MEDLINE]Related articles

    20.

    WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.

    Bouzakri K, Roques M, Debard C, Berbe V, Rieusset J, Laville M, Vidal H.

    Diabetologia. 2004 Jul;47(7):1314-23. Epub 2004 Jun 26.PMID: 15292987 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data